Laman UtamaAVHHL • OTCMKTS
add
AVITA Medical Inc
Tutup sebelumnya
$1.55
Julat tahun
$1.41 - $3.22
Permodalan pasaran
227.57J USD
Bilangan Purata
135.00
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 19.55J | 43.25% |
Perbelanjaan pengendalian | 30.16J | 44.75% |
Pendapatan bersih | -16.20J | -86.01% |
Margin untung bersih | -82.91 | -29.85% |
Pendapatan bagi setiap syer | -0.93 | -75.60% |
EBITDA | -13.50J | -47.63% |
Kadar cukai berkesan | 0.17% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 44.40J | -26.14% |
Jumlah aset | 81.05J | 0.05% |
Jumlah liabiliti | 68.82J | 281.59% |
Jumlah ekuiti | 12.23J | — |
Syer tertunggak | 26.22J | — |
Harga kepada buku | 3.30 | — |
Pulangan pada aset | -40.88% | — |
Pulangan pada modal | -54.41% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -16.20J | -86.01% |
Tunai daripada operasi | -7.21J | 19.61% |
Tunai daripada pelaburan | 7.39J | -66.02% |
Tunai daripada pembiayaan | 1.01J | 67.83% |
Perubahan bersih dalam tunai | 1.19J | -91.12% |
Aliran tunai bebas | -5.35J | 35.08% |
Perihal
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Diasaskan
1999
Ibu pejabat
Tapak web
Pekerja
207
